Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS2 | P35354 | 13/20 | 0.47 |
| ▸ | PTGS1 | P23219 | 8/20 | 0.47 |
| ▸ | CA1 | P00915 | 4/20 | 0.47 |
| ▸ | CA2 | P00918 | 4/20 | 0.47 |
| ▸ | CA4 | P22748 | 4/20 | 0.47 |
| ▸ | CA9 | Q16790 | 4/20 | 0.47 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8828054 | 0.88 | PTGS2 (0.47) | PTGS2PTGS1CA1CA2CA4 | |
| SCHEMBL8933887 | 0.79 | PTGS2 (0.71) | PTGS2PTGS1CA1CA2CA4 | |
| SCHEMBL6352832 | 0.71 | CA1 (0.68) | PTGS2PTGS1CA1CA2CA4 | |
| SCHEMBL8474734 | 0.71 | PTGS2 (0.71) | PTGS2PTGS1CA1CA2CA4 | |
| SCHEMBL8470632 | 0.71 | PTGS2 (0.68) | PTGS2PTGS1CA1CA2CA4 | |
| SCHEMBL6341313 | 0.69 | PTGS2 (0.83) | PTGS2PTGS1CA1CA2CA4 | |
| SCHEMBL6343174 | 0.69 | CA1 (0.68) | PTGS2PTGS1CA1CA2CA4 | |
| SCHEMBL8993386 | 0.67 | PTGS2 (0.33) | PTGS2PTGS1CA1CA2CA4 | |
| SCHEMBL6352141 | 0.65 | PTGS2 (0.51) | PTGS2PTGS1CA1CA2CA4 | |
| SCHEMBL8933959 | 0.65 | PTGS2 (0.71) | PTGS2PTGS1CA1CA2CA4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5547975-A | ANTIARTHRIC AGENTS, ANALGESICS AND ANTIPYRETICS; INHIBITORS OF CYCLOOXYGENASE II; SIDE EFFECT REDUCTION | G.D. SEARLE & CO. | 1996-08-20 | — | — | US | disclosed |